Illustrative image – not actual.Grandix Pharma is setting up a formulations unit near Chennai, entailing an investment of Rs.11 crore.
The plant, with a capacity of 9 million tablets per annum, has been designed and developed to conform to US regulatory norms. The plant will manufacture tablets in the therapeutic segments excluding antibiotics. About 50 per cent of the annual production is targeted for exports.
It may be mentioned that Grandix Pharma, owned by a group of 490 doctors from Chennai, is engaged in marketing formulations since 1996.
